Prio Wealth Limited Partnership’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-7,856
Closed -$219K 252
2022
Q4
$219K Sell
7,856
-1,202
-13% -$30.7K 0.01% 237
2022
Q3
$212K Sell
9,058
-901
-9% -$27.2K 0.01% 235
2022
Q2
$336K Sell
9,959
-2,900
-23% -$102K 0.01% 212
2022
Q1
$449K Sell
12,859
-3,824
-23% -$131K 0.01% 200
2021
Q4
$508K Sell
16,683
-8,316
-33% -$271K 0.02% 199
2021
Q3
$820K Sell
24,999
-34,513
-58% -$1.1M 0.03% 158
2021
Q2
$1.8M Buy
+59,512
New +$1.96M 0.06% 123

Other funds holding OGN

Prio Wealth Limited Partnership's OGN Position: Q1 2023 in Review

Prio Wealth Limited Partnership sold out of Organon & Co (OGN) in Q1 2023, closing a stake of 7,856 shares — an estimated $219K sold.

Prio Wealth Limited Partnership first reported a position in OGN in Q2 2021 and held it in 7 quarters. The position peaked at $1.8M in Q2 2021. 767 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

  • Prio Wealth Limited Partnership reported no remaining Organon & Co position as of Q1 2023 after selling out during the quarter.
  • Prio Wealth Limited Partnership sold 7,856 Organon & Co shares in Q1 2023, an estimated $219K.
  • Prio Wealth Limited Partnership first reported a position in Organon & Co in Q2 2021 and held it in 7 quarters.
  • Prio Wealth Limited Partnership's Organon & Co position peaked at $1.8M in Q2 2021.
  • 767 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on Prio Wealth Limited Partnership's 13F filing for Q1 2023, filed 12 May 2023.